NWL
66
-3
AVY
51
-2
F
40
-3
HIG
54
2
MTB
42
-4
FIS
50
4
FOXA
57
-2
PFG
33
-3
PDCO
75
10
CCL
72
2
HSY
38
-7
FLR
52
4
GOOGL
72
5
NVDA
54
3
PVH
62
2
GE
58
-2
BBY
48
2
MCD
57
-5
PPG
60
-4
XEL
53
-2
NWL
66
-3
AVY
51
-2
F
40
-3
HIG
54
2
MTB
42
-4
FIS
50
4
FOXA
57
-2
PFG
33
-3
PDCO
75
10
CCL
72
2
HSY
38
-7
FLR
52
4
GOOGL
72
5
NVDA
54
3
PVH
62
2
GE
58
-2
BBY
48
2
MCD
57
-5
PPG
60
-4
XEL
53
-2
Financhill
Back

Allspring Global Dividend Opportunity Fund Vs. Aligos Therapeutics Industry Stock Comparison

Buy
56

EOD
Allspring Global Dividend Opportunity Fund

Last Price:
4.92
Seasonality Move:
-0.09%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
35.13
Seasonality Move:
10.65%
Buy
56
Allspring Global Dividend Opportunity Fund (EOD) is a Buy

Is Allspring Global Dividend Opportunity Fund a Buy, Sell or Hold?

  • The current Allspring Global Dividend Opportunity Fund [EOD] share price is $5.08. The Score for EOD is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • EOD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EOD Stock Price Chart

What is Allspring Global Dividend Opportunity Fund's stock price today?

  • The Allspring Global Dividend Opportunity Fund share price today is $5.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EOD is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

EOD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 63.72 Buy
Chaikin Money Flow: -13694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.9 - 5.04) Buy
Bollinger Bands (100): (4.8 - 5) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

EOD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.05 Buy
20-day SMA: 4.97 Buy
50-day SMA: 4.95 Buy
200-day SMA: 4.82 Buy
8-day EMA: 5.05 Buy
20-day EMA: 5 Buy
50-day EMA: 4.95 Buy
200-day EMA: 4.8 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Allspring Global Dividend Opportunity Fund Earnings Growth & EOD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Allspring Global Dividend Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):